Live feed08:05:00·16mPRReleasevia QuantisnowAtara Biotherapeutics Reports that the Tabelecleucel Biologics License Application Has Been Resubmitted to the U.S. Food and Drug AdministrationByQuantisnow·Wall Street's wire, on your screen.ATRA· Atara Biotherapeutics Inc.Health Care
